Member info
Dr Jose M. Caminal
Representative
Spain
Working Group(s): Retinal Rare Eye Diseases (WG1)
Team
Dr Estefania Cobos
Spain
Genetic Diagnostics (TWG6), Registries & Epidemiology (TWG7), Research (TWG8), Retinal Rare Eye Diseases (WG1)
Optometrist Merce Badia
Spain
CPMS & Digital Medecine (TWG10), Genetic Diagnostics (TWG6), National Integration (TWG9), Neuro-Ophthalmology Rare Diseases (WG2), Research (TWG8), Retinal Rare Eye Diseases (WG1)
Optometrist Marta Senau
Spain
Anterior Segment Rare Eye Diseases (WG4), Genetic Diagnostics (TWG6), Low Vision Daily Life and Patients Groups (TWG5), Retinal Rare Eye Diseases (WG1)
Optometrist David Mejias
Spain
Anterior Segment Rare Eye Diseases (WG4), Low Vision Daily Life and Patients Groups (TWG5), Retinal Rare Eye Diseases (WG1)
Nurse Mercedes Moral
Spain
CPMS & Digital Medecine (TWG10), National Integration (TWG9), Neuro-Ophthalmology Rare Diseases (WG2), Retinal Rare Eye Diseases (WG1)
HCP Center
The Department of Ophthalmology of Bellvitge University Hospital takes care of specialized diagnosis and treatment for complex ophthalmology...
contact
Hospital Universitari de Bellvitge, Spain
C/ de la Feixa Llarga s/n
8907 Hospitalet de Llobregat. Barcelona
Spain
Clinical trials
NCT04270747 Completed
A Randomized, Double-masked, Phase 3 Study of ABP 938 Efficacy and Safety Compared to Aflibercept (Eylea®) in Subjects With Neovascular Age-related Macular Degeneration
Interventional